Clinical and Molecular Studies in Families With Inherited Eye Disease



Status:Recruiting
Conditions:Ocular
Therapuetic Areas:Ophthalmology
Healthy:No
Age Range:4 - Any
Updated:4/6/2019
Start Date:May 12, 2016
End Date:February 1, 2026
Contact:James F Hejtmancik, M.D.
Email:f3h@helix.nih.gov
Phone:(301) 435-1598

Use our guide to learn which trials are right for you!

Background:

Genes are the basic units of heredity. When genes are changed, certain cells don t work like
they should. Researchers want to try to better understand the genetic conditions that are
linked with inherited eye diseases.

Objective:

To try to identify the genes linked to the development of inherited eye diseases.

Eligibility:

People ages 4 and older who have or have a family member with an inherited eye disease

Design:

Participants will be screened with medical history and medical records.

Participants will have one visit that will take 3 4 hours. This will include:

Medical and family history

Eye exam: This includes the pupil being dilated.

Electroretinography: A small electrode is taped to the forehead. Participants sit in the

dark with their eyes patched for 30 minutes. Then numbing drops and contact lenses are put in

the eyes. They will watch flashing lights.

Blood tests

Saliva sample: They will spit into a container or have the inside of their cheek swabbed.

Genetic testing will be done on participants blood or saliva.

Participants may meet with the researchers to discuss their genetic tests.

Objective: This project, Clinical and Molecular Studies in Families with Inherited Eye
Disease will study inherited eye diseases, both Mendelian and complex age related inherited
eye diseases, in families of many nationalities and ethnic backgrounds in order to identify
the genes that, when mutated, cause inherited eye diseases and the pathophysiology through
which they act. Among the diseases studied will be cataracts, corneal dystrophies and other
corneal diseases, retinal degenerations, myopia and other anterior chamber defects, and
glaucoma.

Study Population: Families and individuals of many nationalities and ethnic backgrounds. We
will study a maximum of 5,000 patients and family members.

Design: The study consists of ascertaining individuals and especially families with multiple
individuals, affected by both congenital and age related inherited eye diseases. These
participants and their families will undergo detailed ophthalmological examinations to
characterize their visual system and determine their affectation status. A blood sample will
be collected from each individual for isolation of DNA and in some individuals for
lymphoblastoid transformation to establish a renewable source of DNA. Linkage analysis,
association analysis, physical mapping, and mutational screening will be carried out to
identify the specific gene and the mutations in it that are associated with inherited eye
disease in the family. Mutation screening may involve Sanger sequencing if a small number of
candidate genes are identified, or whole genome or whole exome sequencing if more genes
remain as viable candidates after the initial analysis. If necessary, the gene product will
be characterized biochemically. The study will enroll participants at NEI and collaborating
institutions.

Outcome Measures: Linkage will be determined using the lod score method, association will be
determined using standard statistical procedures to estimate p values, and mutations in
specific genes will be assessed using a combination of residue conservation, blosum score,
bioinformatic prediction of structural damage to the protein, and molecular modeling.
Assessment of biochemical, metabolic, and physiological effects of these mutations will be
individualized to the specific case.

- INCLUSION CRITERIA:

To be eligible, the following inclusion criteria must be met, where applicable;

1. Participant must be four years of age or older.

2. Participant must understand and sign the protocol s informed consent document.

3. Individuals or family members of individuals with inherited eye diseases, either
congenital, childhood, or age related.

4. All participants must be able to cooperate with study examination and phlebotomy.

EXCLUSION CRITERIA:

A participant is not eligible if any of the following exclusion criteria are present:

1. Participant has a disease, infection, or trauma that mimic inherited cataracts,
retinal degenerations, glaucoma, etc.

2. Participant has a significant active infection (an infection requiring treatment as
determined by the investigator) or a history of chronic or recurrent infections.

3. Participant requires sedation for study procedures.
We found this trial at
5
sites
Durham, North Carolina 27710
Phone: Not Listed
?
mi
from
Durham, NC
Click here to add this to my saved trials
Los Angeles, California 90095
310-825-4321
Phone: Not Listed
University of California at Los Angeles The University of California, Los Angeles (UCLA) is an...
?
mi
from
Los Angeles, CA
Click here to add this to my saved trials
9000 Rockville Pike
Bethesda, Maryland 20892
301-496-2563
Phone: 800-411-1222
National Institutes of Health Clinical Center The National Institutes of Health (NIH) Clinical Center in...
?
mi
from
Bethesda, MD
Click here to add this to my saved trials
Guangzhou, 528403
?
mi
from
Guangzhou,
Click here to add this to my saved trials
9500 Gilman Dr
La Jolla, California 92093
(858) 534-2230
Phone: Not Listed
The University of California, San Diego UC San Diego is an academic powerhouse and economic...
?
mi
from
La Jolla, CA
Click here to add this to my saved trials